Phase I study of neoadjuvant chemoradiotherapy consisting of S-1 and cisplatin for patients with resectable advanced gastric cancer (KOGC-01)

Anticancer Research

Volumn 31, Issue 9, 2011, Pages 3079-3083

  Takahashi, Tsunehiro ^a   Saikawa, Yoshiro ^a   Takaishi, Hiromasa ^a   Takeuchi, Hiroya ^a   Wada, Norihito ^a   Oyama, Takashi ^a   Fukuda, Kazumasa ^a   Fukada, Junichi ^a   Kawaguchi, Osamu ^a   Shigematsu, Naoyuki ^a   Kitagawa, Yuko ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Cisplatin; Gastric cancer; Neoadjuvant chemoradiotherapy; S 1

Indexed keywords

CISPLATIN; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR;

ADJUVANT CHEMOTHERAPY; ADULT; ADVANCED CANCER; AGED; ANASTOMOSIS LEAKAGE; ANEMIA; ANOREXIA; ARTICLE; BONE MARROW SUPPRESSION; CANCER SURGERY; CHEMORADIOTHERAPY; CHYLOUS ASCITES; CLINICAL ARTICLE; DISTANT METASTASIS; FEMALE; GASTRECTOMY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LEUKOPENIA; LYMPH NODE METASTASIS; MALE; MAXIMUM TOLERATED DOSE; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; PANCREAS FISTULA; PHASE 1 CLINICAL TRIAL; PNEUMONIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RADIATION DOSE; RECOMMENDED DRUG DOSE; SIDE EFFECT; STOMACH CANCER; THERAPY DELAY; THROMBOCYTOPENIA; TREATMENT OUTCOME; TREATMENT RESPONSE;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DRUG COMBINATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; OXONIC ACID; STOMACH NEOPLASMS; TEGAFUR;

EID: 80051639103     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Sano T, Sasako M, Kinoshita T and Maruyama K: Recurrence of early gastric cancer. Follow-up of 1475 patients and review of the Japanese literature. Cancer 72: 3174-3178, 1993.
2. Japanese Gastric Cancer Association Registration Committee, Maruyama K, Kaminishi M, Hayashi K, Isobe Y, Honda I, Katai H, Arai K, Kodera Y and Nashimoto A: Gastric cancer treated in 1991 in Japan: data analysis of nationwide registry. Gastric Cancer 9: 51-66, 2006.
3. Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stermmermann GN, Haller DG, Ajani JA, Gunderson LL, Jessup JM and Martenson JA: Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345: 725-730, 2001.
4. Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, Furukawa H, Nakajima T, Ohashi Y, Imamura H, Higashino M, Yamamura Y, Kurita A and Arai K; ACTS-GC Group Japanese: Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 357: 1810-1820, 2007.
5. Nakajima T, Kinoshita T, Nashimoto A, Sairenji M, Yamaguchi T, Sakamoto J, Fujiya T, Inada T, Sasako M and Ohashi Y; National Surgical Adjuvant Study of Gastric Cancer Group: Randomized controlled trial of adjuvant uracil-tegafur versus surgery alone for serosa-negative, locally advanced gastric cancer. Br J Surg 94: 1468-1476, 2007. (Pubitemid 350275624)
6. Yoshikawa T, Sasako M, Yamamoto S, Sano T, Imamura H, Fujitani K, Oshita H, Ito S, Kawashima Y and Fukushima N: Phase II study of neoadjuvant chemotherapy and extended surgery for locally advanced gastric cancer. Br J Surg 96: 1015-1022, 2009.
7. Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, Scarffe JH, Lofts FJ, Falk SJ, Iveson TJ, Smith DB, Langley RE, Verma M, Weeden S and Chua YJ, for the MAGIC Trial Participants: Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355: 11-20, 2006.
8. Fushida S, Fujimura T, Oyama K, Yagi Y, Kinoshita J and Ohta T: Feasibility and efficacy of preoperative chemotherapy with docetaxel, cisplatin and S-1 in gastric cancer patients with paraaortic lymph node metastases. Anti-cancer Drugs 20: 752-756, 2009.
9. Nashimoto A, Yabusaki H, Nakagawa S, Takii Y, Tsuchiya Y and Otsuo T: Preoperative chemotherapy with S-1 and cisplatin for highly advanced gastric cancer. Anticancer Res 29: 4689-4696, 2009.
10. Schuhmacher C, Gretschel S, Lordick F, Reichardt P, Hohenberger W, Eisenberger CF, Haag C, Mauer ME, Hasan B, Welch J, Ott K, Hoelscher A, Schneider PM, Bechstein W, Wilke H, Lutz MP, Nordlinger B, Cutsem EV, Siewert JR and Schlag PM: Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954. J Clin Oncol 28: 5210-5218, 2010.
11. Koizumi W, Narahara H, Hara T, Takagane A, Akiya T, Takagi M, Miyashita K, Nishizaki T, Kobayashi O, Takiyama W, Toh Y, Nagaie T, Takagi S, Yamamura Y, Yanaoka K, Orita H and Takeuchi M: S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol 9: 215-221, 2008.
12. Takahashi T, Saikawa Y, Kubota T, Akiba Y, Shigematsu N, Yoshida Y, Otani Y, Kumai K, Hibi T and Kitajima M: Histological complete response in a case of advanced gastric cancer treated by chemotherapy with S-1 plus low-dose cisplatin and radiation. Jpn J Clin Oncol 33: 584-588, 2003. (Pubitemid 43108659)
13. Saikawa Y, Kubota T, Takahashi T, Akatsu Y, Nakamura R, Yoshida M, Shigematsu N, Otani Y, Kumai K, Hibi T and Kitajima M: Is chemoradiation effective or harmful for Stage IV gastric cancer patients? Oncol Rep 13: 865-70, 2005.
14. Saikawa Y, Kubota T, Kumagai K, Nakamura R, Kumai K, Shigematsu N, Kubo A, Kitajima M and Kitagawa Y: Phase II study of chemoradiotherapy with S-1 and low-dose cisplatin for inoperable advanced gastric cancer. Int J Radiat Oncol Biol Phys 71: 173-179, 2008. (Pubitemid 351491397)
15. Japanese Research Society for Gastric Cancer: Japanese Classification of Gastric Carcinoma 2nd English Edition. Gastric Cancer 1: 10-24, 1998.
16. Japanese translation of common terminology criteria for adverse events (CTCAE), and instructions and guidelines. Int J Clin Oncol Suppl 3: 1-82, 2004.
17. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC and Gwyther SG: New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92: 205-216, 2000.
18. Ajani JA, Winter K, Okawara GS, Donohue JH, Pisters PW, Crane CH, Greskovich JF, Anne PR, Bradley JD, Willett C and Rich TA: Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response. J Clin Oncol 24: 3953-3958, 2006. (Pubitemid 46630744)